Back
Cellectar Biosciences 10K Form
Sell
40
CLRB
Cellectar Biosciences
Last Price:
$0.26
Seasonality Move:
-2.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLRB News And Ratings
See the #1 stock for the next 7 days that we like better than CLRB
CLRB Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-9.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.04 |
| Price / Book: | 7.34 |
Profitability
| EPS (TTM): | -1.90000 |
|---|---|
| Net Income (TTM): | $-50.1M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Cellectar Biosciences Earnings Forecast
Key Cellectar Biosciences Financial Ratios
-
The Interest Expense is 0.00% of Operating Income.
-
Per Share Earnings over the last 19 years have been positive in 15 years.
Cellectar Biosciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CLRB |
| CUSIP: | 15117F |
| Website: | cellectar.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CLRB Technical Analysis vs Fundamental Analysis
Sell
40
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy or a Sell?
-
Cellectar Biosciences stock is rated a SellThe current Cellectar Biosciences [CLRB] share price is $0.28. The Score for CLRB is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.